相关实验视频

Updated: Sep 19, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

针治疗治疗辐射诱导的口症的有效性:一个更新的元分析

Ru-Yin Tsai^1,2, Sheng-Yi Lin^1,2, Chin-Chang Chen^1,2

¹Department of Anatomy, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan. geoge6211@csmu.edu.tw (CCC); shengyi@csmu.edu.tw (SYL).

International journal of medical sciences

|June 16, 2025

概括

针有效地增加了唾液流量,并改善了辐射引起的口腔干燥 (xerostomia) 的患者的生活质量. 与传统治疗相比,这种非药理学方法可以显著缓解症状.

科学领域:

在瘤学瘤学.
综合医学是一个整体的医学.
基于证据的实践.

背景情况:

头癌的放射治疗通常会导致口腔干燥 (xerostomia).
现有的异口症治疗方法往往提供有限的缓解,并带有副作用.
针正在被研究作为一种非药物选择,用于管理辐射诱导的口症.

研究的目的:

系统地审查和元分析针在改善辐射诱导异口症患者的症状和生活质量的有效性.
评估针对唾液流和患者报告结果的影响.

主要方法:

在主要数据库 (MEDLINE,Embase,Cochrane Central,Web of Science) 进行系统的文献搜索.
包括随机对照试验 (RCT) 评估成年人中治疗辐射诱导的.
使用随机效应模型进行元分析,以合成关于唾液流量,症状严重程度和生活质量的数据.

主要成果:

对11项与1271名参与者进行的RCT的分析表明,针治疗中唾液流量 (休息和刺激) 适度增加.
与对照组相比,针显著降低了异口症症状,改善了生活质量得分.
传统的针显示出比通过皮肤电神经刺激 (TENS) 更高的疗效.

结论:

针显示承诺作为一个有效的补充疗法,用于管理辐射诱导的异口症.
它为癌症患者提供症状缓解和潜在的生活质量改善.
需要进一步的研究来标准化针方案,以获得一致的结果.

关键词:

癌症癌症癌症癌症癌症干燥的嘴巴干燥的嘴巴生活质量.生活质量.唾液流的流量唾液流系统性审查是系统的审查.

更多相关视频

Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension

Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...